Considerations Of Particle Analysis 12of35 Complex Generics Sep 25 26 2019

Xiaoming Xu from the CDER Office of Pharmaceutical Division of Product Quality provides an overview of research, development, ...

Lisa Bercu, Bing Cai, Kimberly Witzmann, Office of

Presenters Cameron Smith, Deyi Zhang, and Xiaoming Xu answer audience questions. Learn more at ...

Michelle Lin from the Division of Clinical Review in the Office of

Presenters Karen Bengtson, Suneela Prodduturi and Susan Zuk answer audience questions. Learn more at ...

Kimberly Witzmann from the Office of Bioequivalence in CDER's Office of

Presenters Yan Wang, Bin Qin, Vidula Kolhatkar, and Bing Cai answer audience questions. Learn more at ...

Yan Wang from the Division of Therapeutic Performance in the CDER Office of

Ross Walenga in the Division of Quantitative Methods and Modeling in the Office of

Xiajing (Jean) Gong from CDER Office

Tannaz Ramezanli from the Division of Therapeutic Performance in the Office of

Liang Zhao from the Division of Quantitative Methods and Modeling in the Office of

Satish Sharan from the Division of Quantitative Methods and Modeling in the Office of

Andrew J. Fine from the Division of Clinical Review in the Office of

Director of the Office of

Lisa Bercu, Regulatory Counsel in the Office of

Deyi Zhang from the Office of Research and Standards in the Office of

Cameron Smith from the Office of Lifecycle Drug Products in the Office of Pharmaceutical Quality covers the regulatory pathway for ...

Bin Qin from the Division of Therapeutic Performance in the Office of

Liang Zhao, Yaning Wang, Robert Lionberger, and Murray Ducharme from Learn and Confirm, Inc., respond to audience ...